Browsing Category
PMC Isochem
Recent advances in the delivery of disulfiram: a critical analysis of promising approaches to…
Background
Disulfiram (DSF) has a long history of being used as a first-line promising therapy for treatment of alcoholism in human. Besides its prominence in the treatment of alcoholism, extensive investigations have been carried out to explore other biomedical and pharmacological effects of…
Read More...
Read More...
Elucidating molecular design principles for charge-alternating peptides
The therapeutic potential of protein drugs has been hindered by difficulties with long-term stability and rapid clearance from the body.
Recombinant fusion proteins provide a scalable platform for engineered biologics, whereby a polypeptide domain is appended to alter the physical characteristics…
Read More...
Read More...
PMC Isochem invests 2 Millions € in R&D
2019 Nov 22
PMC Isochem invests 2 Millions € in new R&D capability: New labs, Kilolab and new analytical technology equipment.
This R&D capability expansion will support CDMO and Polyamino acids for Drug delivery business growth.
About PMC Isochem:
PMC Isochem…
Read More...
Read More...
Announcement: STEP Database Updated – 29 Excipients now!
08. June 2015
Announcement: STEP Database Updated – 29 Excipients now!
The STEP stands for Safety and Toxicity of Excipients for Paediatrics. The Safety and Toxicity of Excipients for Paediatrics (STEP) Database is a user-designed resource developed by European Paediatric Formulation…
Read More...
Read More...